詳情介紹
公司：www.apotech.com
Apotech 公司在瑞士的日內瓦，成立于2000年，供應生命科學用的試劑，其創新的試劑盒產品廣泛應用于細胞凋亡，免疫，神經科學信號轉導和炎癥等領域，并得到了廣泛的認可，成功地為其塑造了認可的Apotech的品牌形象，同時Apotech的高質量重組蛋白和抗體也是*的高質量產品，這些都為確立了Apotech在該領域中的。
Highest Standards for Research Kits™
APOTECH Corporation is a worldwide producer and distributor of life science reagents. ApoTech is a leading supplier of new & innovative research kits and sets in the field of apoptosis, immunology and inflammation.
Research kits and sets available from ApoTech include:
- Omentin Detection Set
- L-33, Soluble Detection Set
- TL1A, Soluble Detection Set
- BAFF, Soluble Detection Set and ELISA Kit
- LAG-3, Soluble Detection Set
- totalRANKL, Soluble ELISA Kit
- CTRP7 Detection Set
- TLR Ligands Set I
ApoTech also offer custom services including:
- Rapid labelling service for proteins and antibodies with fluorescent dyes, biotin or HRP
- Custom production （to mg scale） of proteins in different systems
- Customised analysis of molecules for measurement in its ability to induce apoptosis and the mode of action
Please contact Sapphire Bioscience directly to: - place an order
- enquire about price & availability
- ask for Technical Assistance
|
Apotech® - A Brand of Enzo Life Sciences, Inc.
Highest Standards for Research Kits™.
APOTECH Corporation was founded in 2000 in Geneva, Switzerland. The company is a globally operating life science reagents company discovering, developing and producing innovative research kits and sets in the field of apoptosis, immunology and inflammation. A comprehensive product offering, combined with outstanding technical information supports researchers in the advancement of their science.
Apotech Corporation is the operational headquarters of Apotech®, an internationally recognized brand acknowledged as a leader in producing high quality recombinant proteins and antibodies in key research areas. The successful Apotech® brand of innovative research kits and sets covers the fields of Apoptosis, Cancer Research, Immunology, Neuroscience, Signal Transduction and Oxidative Stress. Selected kits with high potential for human diagnostics applications are outlicensed to specialized companies in the field.
On April 29, 2005 AXXORA Life Sciences Inc. and APOTECH Corporation announced the merger of the two companies. Following this merger the companies continued operating from their respective headquarters in San Diego, CA, USA and Epalinges, Switzerland, and under their current management teams.
The merger has resulted in APOTECH Corporation operating as a new business division of AXXORA Life Sciences Inc., and a member of the AXXORA Platform （www.axxora.com）. APOTECH’s cutting edge product line and know-how in recombinant proteins, antibodies and ELISA kits strengthens the group as a manufacturer and single-source supplier of over 14,000 life science reagents and research kits to researchers worldwide.
Prior to the transaction the two companies had a longstanding successful business relationship through distribution and co-development agreements. The merger has strengthened the company’s ability to provide its customers with superior service, innovative products, and enhanced production capabilities.
